MCG scan study for cardiac amyloidosis
Part of Hormones & metabolism clinical trials.
This study uses a new type of heart scan (MCG) to help understand cardiac amyloidosis. It may help doctors learn more about the condition without needing invasive tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must be able to follow the study rules and give written permission
- You must not be pregnant or breastfeeding
- You must not have active atrial fibrillation on your most recent EKG
- You must not have metal implants in your chest (like a pacemaker or defibrillator)
- You must be able to lie still on your back for the scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special MRI scan to measure how stiff the heart muscle is in people with cardiac amyloidosis. The goal is to better understand the condition and potentially guide future treatments.
This study tests a new magnetic heart scan (MCG) to see if it can better detect blocked arteries causing chest pain or heart attacks. It may help doctors decide the best treatment for you.
This study enrolls patients suspected of having or recently diagnosed with cardiac amyloidosis—a condition where abnormal protein deposits thicken the heart muscle. Researchers will use imaging tests like echocardiography and MRI to better understand the disease and track how it changes over time, which may improve future treatment options.
This trial checks how accurate a magnetocardiography (MCG) scan is in people who are being evaluated for possible coronary artery disease. It may help doctors choose better diagnostic tests by comparing the scan results to the standard evaluation you are already getting.
This trial aims to better diagnose cardiac amyloidosis — a condition where abnormal proteins build up in the heart — by testing whether certain warning signs (called 'red flags') can help identify it. If you have any of these signs, the study will use heart scans to confirm the diagnosis.
This study looks at how a type of heart condition called transthyretin cardiac amyloidosis changes over time, using a special imaging test called a bone scan. The goal is to see if the scan can help track the disease and potentially improve care.
Hear when a new Amyloidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.